ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2017

PI3K/AKT inhibitors in patients with refractory renal cell carcinoma: what have we learnt so far?

P J Vlachostergios et al.PubMed ↗Publisher ↗

No numbers read from the abstract.